Portage Biotech (Portage Biotech) FCF Yield % : -231.67 (As of May. 11, 2024)

View and export this data going back to . Start your Free Trial

What is Portage Biotech FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Portage Biotech's Trailing 12-Month Free Cash Flow is $-11.57 Mil, and Market Cap is $4.99 Mil. Therefore, Portage Biotech's FCF Yield % for today is -231.67%.

The historical rank and industry rank for Portage Biotech's FCF Yield % or its related term are showing as below:

PRTG' s FCF Yield % Range Over the Past 10 Years
Min: -231.67 Med: 15.12 Max: 16630.74
Current: -231.67

During the past 13 years, the highest FCF Yield % of Portage Biotech was 16630.74%. The lowest was -231.67%. And the median was 15.12%.

PRTG's FCF Yield % is ranked worse than
92.8% of 1556 companies
in the Biotechnology industry
Industry Median: -14.17 vs PRTG: -231.67

Portage Biotech's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

Portage Biotech FCF Yield % Historical Data

The historical data trend for Portage Biotech's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Portage Biotech FCF Yield % Chart

Portage Biotech Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

FCF Yield %

Get a 7-Day Free Trial

-0.80

-3.71

-1.27

-7.71

-22.20

Portage Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-11.98	-34.42	-22.22	-	-38.13

Competitive Comparison of Portage Biotech's FCF Yield %

For the Biotechnology subindustry, Portage Biotech's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Portage Biotech's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Portage Biotech's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Portage Biotech's FCF Yield % falls into.

Portage Biotech FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Portage Biotech's FCF Yield % for the fiscal year that ended in Mar. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-12.076	/	54.401613
	=	-22.20%

Portage Biotech's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-3.431	*	4	/	35.996324
	=	-38.13%

Portage Biotech FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Portage Biotech FCF Yield % Related Terms

Thank you for viewing the detailed overview of Portage Biotech's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Portage Biotech (Portage Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Portage Biotech Inc (NAS:PRTG) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Clarence Thomas Building, P.O. Box 4649, Tortola, Road Town, VGB, VG1110

Website

https://www.portagebiotech.com

Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.